US Bancorp’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-529
Closed -$20.4K 4171
2025
Q1
$20.4K Hold
529
﹤0.01% 3161
2024
Q4
$20.1K Buy
+529
New +$21.1K ﹤0.01% 3159
2024
Q2
Sell
-200
Closed -$8.29K 3986
2024
Q1
$8.29K Buy
+200
New +$8.38K ﹤0.01% 3398
2019
Q3
Sell
-2,340
Closed -$91K 3582
2019
Q2
$91K Hold
2,340
﹤0.01% 2262
2019
Q1
$93K Hold
2,340
﹤0.01% 2226
2018
Q4
$85K Hold
2,340
﹤0.01% 2206
2018
Q3
$100K Hold
2,340
﹤0.01% 2221
2018
Q2
$90K Buy
+2,340
New +$84.8K ﹤0.01% 2297

Other funds holding BME

US Bancorp's BME Position: Q2 2025 in Review

US Bancorp sold out of BlackRock Health Sciences Trust (BME) in Q2 2025, closing a stake of 529 shares — an estimated $20.4K sold.

US Bancorp first reported a position in BME in Q2 2018 and held it in 8 quarters. The position peaked at $100K in Q3 2018. 72 funds tracked by Wall St. Rank hold BME as of Q2 2025.

  • US Bancorp reported no remaining BlackRock Health Sciences Trust position as of Q2 2025 after selling out during the quarter.
  • US Bancorp sold 529 BlackRock Health Sciences Trust shares in Q2 2025, an estimated $20.4K.
  • US Bancorp first reported a position in BlackRock Health Sciences Trust in Q2 2018 and held it in 8 quarters.
  • US Bancorp's BlackRock Health Sciences Trust position peaked at $100K in Q3 2018.
  • 72 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2025.

Based on US Bancorp's 13F filing for Q2 2025, filed 24 Jul 2025.